Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials.

Fey, Martin F; O'Reilly, Seamus; Awada, Ahmad H; Crowley, John; Gelmon, Karen A (2024). Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials. Current opinion in oncology, 36(5), pp. 418-420. Wolters Kluwer Health 10.1097/CCO.0000000000001056

[img] Text
diligent_use_of_meddra_terminology_and_preferred.15.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (728kB)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Fey, Martin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1531-703X

Publisher:

Wolters Kluwer Health

Language:

English

Submitter:

Pubmed Import

Date Deposited:

07 Aug 2024 08:02

Last Modified:

07 Aug 2024 08:11

Publisher DOI:

10.1097/CCO.0000000000001056

PubMed ID:

39106404

BORIS DOI:

10.48350/199537

URI:

https://boris.unibe.ch/id/eprint/199537

Actions (login required)

Edit item Edit item
Provide Feedback